|1.||Tong, Xiao-Mei: 1 article (12/2013)|
|2.||Xing, Yan: 1 article (12/2013)|
|3.||Tzimas, T: 1 article (04/2013)|
|4.||Akritidis, N: 1 article (04/2013)|
|5.||Tsoumpris, A: 1 article (04/2013)|
|6.||Gkabrelas, K: 1 article (04/2013)|
|7.||Kim, Yun Hwan: 1 article (01/2009)|
|8.||Chung, Hyun Hoon: 1 article (01/2009)|
|9.||Kim, Young Tae: 1 article (01/2009)|
|10.||Kang, Soon-Beom: 1 article (01/2009)|
|1.||Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/01/2005 - "Iron protein succinylate is an effective and well tolerated treatment of iron-deficiency anemia in pregnancy."
01/01/2005 - "The aim of this study was to evaluate the efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy. "
01/01/2005 - "The efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy."
12/01/2002 - "[Iron protein-succinylate in the treatment of adult iron-deficiency anemia]."
12/01/2013 - "[Clinical study of iron protein succinylate oral solution for preventing and treating anemia of prematurity]."
12/01/2013 - "To evaluate the efficacy and safety of iron protein succinylate (IPS) oral solution in preventing and treating anemia of prematurity (AOP). "
06/01/1998 - "One-hundred children, 48 males and 52 females, mean age +/- SD 39.9 +/- 28.2 months (range 12 to 113) with sideropenia or sideropenic anemia were randomly divided into 2 groups of 50 patients each (groups A and B) and were treated with iron protein succinylate (group A) or iron hydroxide polymaltose complex (group B). "
03/01/1993 - "A prospective, controlled, double-blind, double-dummy, multicenter clinical trial was made to assess the efficacy and tolerability of iron-protein-succinylate (ITF 282) in comparison with a well known iron preparation in the treatment of iron deficiency or iron deficient anemia. "
01/01/2009 - "The aim of this study was to compare the efficacy, safety and achievement of the target hemoglobin level (Hb >or=10 g/dl) in patients with preoperative anemia due to menorrhagia who received intravenous iron sucrose compared with oral iron protein succinylate for anemia management. "
|2.||saccharated ferric oxide
|4.||iron succinyl milk protein complex